Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 54 of 54 publications.

Mosis G, Gutierrez LP, Dieleman J, Castellsague J, Sturkenboom M. No changes in channeling of COX-2 Specific inhibitors in the first three years after marketing. Poster presented at the ISoP Annual Conference ‘Pharmacovigilance in Clinical Practice’; October 2003. Marrakech, Morocco. [abstract] Pharmacoepidemiol Drug Saf. 2003 Oct; 12(S2):S243.

Gutierrez LP, Maguire A. Prevalence estimation for rare neoplasms: chronic myeloid leukemia. Poster presented at the 17th International Conference on Pharmacoepidemiology; August 26, 2001. Toronto, Canada.

Varas-Lorenzo C, Perez-Gutthann S, Castellsague J, Gutierrez LP. Effects of transdermal hormone replacement therapy on cardiovascular outcomes: epidemiological evidence. In: Genazzani AR, editors. Hormone replacement therapy and cardiovascular disease. New York: United States. The Partenon Publishing Group Limited; 2001.

Gutierrez LP. Patterns and prevalence of use of Vivelle®, Estraderm® and oral premarin among women 45 years and older in a US managed health care setting. Poster presented at the 16th International Conference on Pharmacoepidemiology; August 2000. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2000 Sep; 9(S1):S150-104.